Berlin (AFP) | 14/07/2025 - 22:09:32 | Merz says Germany to play 'decisive role' in US-NATO weapons deal for Ukraine
Kyiv (AFP) | 14/07/2025 - 21:51:59 | Zelensky says discussed 'solutions' to protect Ukraine in Trump call
Port Sudan (AFP) | 14/07/2025 - 21:41:37 | Paramilitary attack kills 48 in central Sudan village: war monitor
Kyiv (AFP) | 14/07/2025 - 21:39:01 | Zelensky says 'grateful' for Trump decision on weapons
Arbil (AFP) | 14/07/2025 - 21:35:32 | Two drones hit oil field in Iraq's Kurdistan region: Kurdish forces
Kyiv (AFP) | 14/07/2025 - 20:07:50 | Ukraine's Zelensky proposes PM as new defence minister
Tehran (AFP) | 14/07/2025 - 18:51:23 | Iran says no nuclear talks if US insists it abandon enrichment: state media
Jerusalem (AFP) | 14/07/2025 - 18:46:51 | Israel says Syria strikes 'a clear warning to the Syrian regime'
Brussels (AFP) | 14/07/2025 - 18:42:02 | EU top diplomat says Trump's 50 day Russia ultimatum 'a very long time'
Al Mazra'ah (AFP) | 14/07/2025 - 18:00:35 | Syria government forces take over Druze village in south: AFP correspondent
Ina Fassbender secured first place for her photograph ‘Looking Forward to Euro’, taken in Essen during the 2024 UEFA European football championship.
AFP’s Global News Director, Phil Chetwynd, appeared on France 24’s Scoop on Friday, 7 February, to discuss artificial intelligence and its impact on journalism.
In a context of widespread disinformation, fact-checking forms the first line of response through its focus on restoring the facts. Fact-checking involves verifying content that has already been published, particularly on social media, and establishing what is known—or not—about a subject.
The work of fact-checkers involves:
Selecting the most sensitive and viral topics;
Conducting thorough verification;
Textron Aviation Inc., a Textron Inc. (NYSE: TXT) company, announced its new multi-mission Beechcraft King Air demonstration aircraft will be making its show and European debut at the 2025 Paris Air Show. The aircraft is equipped to showcase a wide range of missions available on the versatile and reliable Beechcraft King Air platform, and will be on static display Monday, June 16, through Thursday, June 19, at the Textron Pavilion A2. This press release features multimedia. View the full relea...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. Prior to this licensing agreement, BeOne Medicines had obtained a license to use Biocytogen’s RenMice® fully human antibody platfo...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully human antibodies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709204455/en/ Prior...
Ant International, a leading global digital payment, and financial technology provider, today unveils its AI strategy with the launch of Alipay+ GenAI Cockpit, an AI-as-a-Service (AIaaS) platform that empowers fintech companies and super apps to build AI-agentic and ultimately AI-native financial services with enhanced efficiency, security, and flexibility. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2...
Samsung Bioepis Co., Ltd. (“Samsung Bioepis”) announced today that the company has entered into a license, development and commercialization agreement with NIPRO Corporation (“NIPRO”) for multiple biosimilar candidates including SB17, ustekinumab biosimilar candidate, in Japan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608582351/en/Samsung Bioepis (President and CEO: Kyung-Ah Kim) has entered into a license, development and ...
